enhanced vulnerability to brain injury. This study sought to evaluate the long-term pediatric neuropsychiatric morbidity, and specifically autistic spectrum disorders (ASD), of children born to obese patients as compared with children born to non-obese mothers. STUDY DESIGN: A population-based cohort analysis was performed comparing all deliveries of obese (maternal pre-pregnancy body mass index of 30 kg/m 2 or more) and non-obese patients between 1991-2014 at a single tertiary medical center. Hospitalizations of the offspring up to the age of 18 years involving neuropsychiatric morbidities were evaluated according to a predefined set of ICD-9 codes, including autistic, eating, sleeping and movement disorders, cerebral palsy, developmental disorders, and more. Kaplan-Meier survival curve was used to compare cumulative hospitalization rate in exposed and unexposed offspring. A Cox proportional hazards model was used to control for confounders. RESULTS: During the study period, 242,342 deliveries met the inclusion criteria. Of them, 3,290 were children of obese mothers. Hospitalizations involving neuropsychiatric morbidities were higher in children born to obese mothers compared with those born to non-obese mothers (4.0% vs. 3.1%, p<0.01, Table) . Specifically, offspring of obese mothers had higher rates of ASD and psychiatric disorders (Table) . The Kaplan-Meier survival curve demonstrated a significant higher cumulative incidence of neuropsychiatric-related hospitalizations in the obese group (Figure, log rank p¼0.03). Using a cox proportional hazards model, controlling for maternal age, preterm labor, maternal diabetes, hypertensive disorders of pregnancy and birthweight, maternal obesity was found to be independently associated with long-term neuropsychiatric morbidity of the offspring (adjusted HR¼1.23, 95% CI 1.04-1.47, p¼0.01). CONCLUSION: Maternal obesity is an independent risk factor for longterm neuropsychiatric morbidity of the offspring, and specifically ASD. However, due to our small numbers, the latter association should be further investigated. OBJECTIVE: Pregnant women with systemic lupus erythematosus (SLE) are at increased risk for adverse pregnancy outcomes (APOs) due to abnormal placentation. Identifying patients destined for APO early in pregnancy would significantly improve their obstetric outcomes. We sought to identify potential proteomic biomarkers in mid-trimester amniotic fluid of pregnant women with SLE for the prediction of APOs. STUDY DESIGN: The study population included 35 pregnant women with SLE who underwent clinically indicated amniocentesis at 15-24 weeks of gestation. Patients were divided into two groups: 19 women with normal pregnancy outcome (Group 1¼control group) and 16 Poster Session IV ajog.org
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Seoul, Korea (Republic of), 3 Biomedical Research Institute, Seoul National University Hospital, Seoul, Seoul, Korea (Republic of) OBJECTIVE: Pregnant women with systemic lupus erythematosus (SLE) are at increased risk for adverse pregnancy outcomes (APOs) due to abnormal placentation. Identifying patients destined for APO early in pregnancy would significantly improve their obstetric outcomes. We sought to identify potential proteomic biomarkers in mid-trimester amniotic fluid of pregnant women with SLE for the prediction of APOs. women who developed APOs (Group 2¼APO group). APO was defined as the development of at least one of the followings: preeclampsia, fetal death in utero, neonatal death before hospital discharge, indicated preterm birth <36 weeks, and small for gestational age (<5th percentile) at birth. Stored samples of amniotic fluids were analyzed using mass spectrometry-based proteomics. In a discovery phase, we analyzed 9 patients (4 in Group 1 and 5 in Group 2) with data-dependent acquisition (DDA) approach. In a verification phase, we analyzed the remained 26 patients (15 in Group 1 and 11 in Group 2) using data-independent acquisition (DIA) method. Hierarchical clustering was performed based on the Euclidean distance and the average linkage. RESULTS: In the discovery phase, 44 proteins were differentially expressed between Group 1 and Group 2. In a verification phase, differentially expressed proteins (DEPs) were verified in independent samples using DIA method. Four proteins including FLNA (filamin A), SVEP1 (sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1), LCAT (lecithin-cholesterol acyltransferase), and TGM2 (transglutaminase 2) were differentially expressed both in discovery and verification phase. In order to select the best combination of proteins for predicting adverse outcomes, three-fold cross validation (CV) with repetition of 100 times was performed. The multi-marker model with 3 biomarkers (SVEP1, LCAT, TGM2) had a high discriminatory power to distinguish between the two groups (the area under the receiver operating characteristic, AUROC ¼ 0.855, p<0.001). CONCLUSION: Our result indicates that increased expression of SVEP1, LCAT, and TGM2 in mid-trimester amniotic fluid may predict APOs in women with SLE. A large scale prospective study is warranted to verify this finding. OBJECTIVE: Our objective was to identify risk factors for maternal depression utilizing the Adverse Childhood Experience (ACE) Questionnaire. STUDY DESIGN: A retrospective chart review from January 2017 until July 2018 of women presenting for prenatal care at our institution. Patients were included that completed both the Edinburgh Postnatal Depression Scale (EPDS) and the ACE questionnaire during the perinatal period. Statistical analysis using Chi-square and twosample t-test was performed, and a P-value of 0.05 was utilized for clinical significance. RESULTS: 60 patients met inclusion criteria. The majority of patients were African American and the average age was 27. Twenty-two percent of patients screened positive for depression in the perinatal period, which is higher than the national average of 14%. Of those that screened positive for depression, 46% endorsed suicidal or homicidal ideation. 80% of patients that screened positive for depression had an adverse childhood experience. The ACE scores ranged from 0 to 8 (maximum score is 10). An ACE score of at least 2 was associated with developing depression in the perinatal period (P-value 0.004). CONCLUSION: The ACE questionnaire is a well-studied screening tool that assesses a history of childhood neglect and abuse on the impact of chronic illness. To our knowledge, it has not been utilized during pregnancy until now. Based on our results, the ACE questionnaire is a tool that can be used to determine individuals at risk of developing perinatal depression. By screening patients earlier for depression utilizing a validated screening tool such as the EPDS, treatment can be initiated sooner, especially in a high risk low socioeconomic patient population where loss to follow up rates are high.
859 Predicting venous thromboembolism in obese pregnant women in a national study OBJECTIVE: Venous thromboembolism (VTE) in pregnancy and postpartum is a leading cause of maternal morbidity and mortality in developed countries, where obesity is a known risk for this complication. Current guidelines vary in which patients qualify for VTE prophylaxis, precluding a uniform approach for management. The purpose of this study was to derive a risk prediction model for VTE in obese pregnant women. STUDY DESIGN: We performed a retrospective cohort analysis using the Consortium on Safe Labor (CSL) database. The CSL includes detailed information from the electronic medical record for >200,000 deliveries from 19 hospitals across the United States from 2002 through 2008. Women ages 16-45 who were pregnant with singletons and had an obese body mass index (BMI>30 kg/m 2 ) were included in our study population. Maternal characteristics and preexisting conditions as well as pregnancy-related conditions and complications were analyzed to identify differences between those had a VTE and those who did not. Multivariable logistic regression was used in order to identify predictors of VTE. RESULTS: Of the 83,500 women who met inclusion criteria, on average women were 27.8 AE 6.0 years old, 38.6 AE 2.21 weeks gestation, with BMI of 35.8 AE 5.45 kg/m 2 , and cesarean delivery incidence of 35.2%. The racial makeup of our cohort was 45.1% Caucasian, 27.2% African American and 20.2% Hispanic women. 109 women (0.13%) experienced a VTE event. Independent predictors of VTE in our final multivariable predictive model included: mode of delivery, BMI, pregestational diabetes, chronic heart disease, preeclampsia, blood transfusion (intrapartum or postpartum), prenatal history of thromboembolic disorder, and postpartum maternal length of stay (Table) . A receiver operating characteristic curve was developed to assess the model; area under the curve was 0.826 ( Figure) .
